Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility

[1]  J. Cuzick,et al.  Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial , 2014, The Lancet.

[2]  G. Giles,et al.  Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre , 2013, British Journal of Cancer.

[3]  Clarice R Weinberg,et al.  Epigenome-wide association study of breast cancer using prospectively collected sister study samples. , 2013, Journal of the National Cancer Institute.

[4]  G. Omenn,et al.  Evolution of Translational Omics: Lessons Learned and the Path Forward , 2013 .

[5]  Jaana M. Hartikainen,et al.  Large-scale genotyping identifies 41 new loci associated with breast cancer risk , 2013, Nature Genetics.

[6]  Stephen R. Piccolo,et al.  A single-sample microarray normalization method to facilitate personalized-medicine workflows. , 2012, Genomics.

[7]  D. Bowtell,et al.  A role for common genomic variants in the assessment of familial breast cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Lewis J. Frey,et al.  ML-Flex: A Flexible Toolbox for Performing Classification Analyses In Parallel , 2012, J. Mach. Learn. Res..

[9]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[10]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[11]  M. Thun,et al.  Performance of Common Genetic Variants in Breast-cancer Risk Models , 2022 .

[12]  D. Saslow,et al.  Cancer Screening in the United States, 2010: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening , 2010, CA: a cancer journal for clinicians.

[13]  A. Børresen-Dale,et al.  Gene expression profiling of peripheral blood cells for early detection of breast cancer , 2010, Breast Cancer Research.

[14]  Ian H. Witten,et al.  The WEKA data mining software: an update , 2009, SKDD.

[15]  Ramil N. Nurtdinov,et al.  PLANdbAffy: probe-level annotation database for Affymetrix expression microarrays , 2009, Nucleic Acids Res..

[16]  Hyun Cheol Chung,et al.  Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer , 2009, PLoS genetics.

[17]  Ben S. Wittner,et al.  Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.

[18]  S. Fox,et al.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers , 2009, Nature Medicine.

[19]  Larry Norton,et al.  Latent bone metastasis in breast cancer tied to Src-dependent survival signals. , 2009, Cancer cell.

[20]  Patricia Greninger,et al.  A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. , 2009, Cancer cell.

[21]  L. Liang,et al.  Mapping complex disease traits with global gene expression , 2009, Nature Reviews Genetics.

[22]  Zhandong Liu,et al.  Singular value decomposition-based regression identifies activation of endogenous signaling pathways in vivo , 2008, Genome Biology.

[23]  John D. Storey,et al.  Mapping the Genetic Architecture of Gene Expression in Human Liver , 2008, PLoS biology.

[24]  Mark Girolami,et al.  BRCA1 and BRCA2 Missense Variants of High and Low Clinical Significance Influence Lymphoblastoid Cell Line Post-Irradiation Gene Expression , 2008, PLoS genetics.

[25]  Eran Segal,et al.  Module map of stem cell genes guides creation of epithelial cancer stem cells. , 2008, Cell stem cell.

[26]  C. Liew,et al.  The peripheral-blood transcriptome: new insights into disease and risk assessment. , 2007, Trends in molecular medicine.

[27]  L. Zon,et al.  Effects of RAS on the genesis of embryonal rhabdomyosarcoma. , 2007, Genes & development.

[28]  T. Barrette,et al.  Molecular concepts analysis links tumors, pathways, mechanisms, and drugs. , 2007, Neoplasia.

[29]  Giovanni Parmigiani,et al.  Meta-analysis of BRCA1 and BRCA2 penetrance. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Fei Huang,et al.  Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection. , 2007, Cancer research.

[31]  P. Sebastiani,et al.  Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer , 2007, Nature Medicine.

[32]  Jeffrey T. Chang,et al.  GATHER: a systems approach to interpreting genomic signatures , 2006, Bioinform..

[33]  Jeffrey T. Chang,et al.  Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.

[34]  Thomas Lengauer,et al.  ROCR: visualizing classifier performance in R , 2005, Bioinform..

[35]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Hall,et al.  An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Molony,et al.  Genetic analysis of genome-wide variation in human gene expression , 2004, Nature.

[38]  P. Butow,et al.  Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer. , 2003, Journal of women's health.

[39]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[40]  D Spiegelman,et al.  Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. , 2001, Journal of the National Cancer Institute.

[41]  J. Peto,et al.  High constant incidence in twins and other relatives of women with breast cancer , 2000, Nature Genetics.

[42]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[43]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[44]  R F Phipps,et al.  Familial breast cancer. , 1988, Postgraduate medical journal.

[45]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[46]  Nazneen Rahman,et al.  The emerging landscape of breast cancer susceptibility , 2007, Nature Genetics.

[47]  J. Sudbø,et al.  Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.

[48]  Vladimir Vapnik,et al.  Statistical learning theory , 1998 .

[49]  Robert Tibshirani,et al.  Fataluku medicinal ethnobotany and the East Timorese military resistance , 2007, Journal of ethnobiology and ethnomedicine.